INBS Completes Interference Study to Support FDA Clearance

Intelligent Bio Solutions has completed an interference study to validate the accuracy of its drug screening system under real-world conditions, solidifying plans to submit the FDA 510(k) package in the second half of 2026 to enter the U.S. market.